Basic Information
ArsenalBio is a programmable cell therapy company dedicated to creating efficient and accessible immune cell therapies for patients. ArsenalBio is committed to integrating technologies such as CRISPR-based genomic engineering, large-scale and high-throughput target identification, synthetic biology, and machine learning to drive the discovery of new paradigms in immune cell therapy.
ArsenalBio Inc.
SanFrancisco,California,United States of America
15~50 people
January 01, 2019
--
